Lisa Salberg sits down with Dr. Nicholas Smedira of the Cleveland Clinic to explore how HCM surgery has evolved over the past three decades. They discuss myectomy, myosin inhibitors, surgical innovation, patient selection, and why experience and high-volume centers continue to matter in achieving the best outcomes for patients.

This conversation was recorded June 8, 2026.

Lisa Salberg welcomes Dr. Ahmed "Sami" Abuzaid to discuss the growth of specialized HCM care in Alaska. They explore building a regional HCM program, expanding access to clinical trials, improving health equity, and what patients need to know about navigating care in remote communities.

This conversation was recorded June 5, 2026.

Lisa Salberg welcomes Dr. Christopher Kramer to discuss groundbreaking findings from the international HCMR Registry. They explore how cardiac MRI, scar burden, heart muscle mass, and biomarkers may improve risk prediction and help shape the future of personalized HCM care.

This conversation was recorded on May 29, 2026

Lisa Salberg and Dr. Alex de Feria explore the latest developments in HCM care, from promising non-obstructive HCM therapies to the challenges of recognizing symptoms, managing medications, and assessing sudden cardiac death risk. They also discuss clinical trials, fibrosis research, and why the future of HCM treatment has never looked brighter.

This conversation was recorded May 28, 2026.

Host Lisa Salberg talks with Dr. Ronald H. Wharton about building a nationally recognized HCM Center of Excellence at Northwell Health on Long Island. They discuss patient education, new myosin inhibitor therapies, clinical trials, and why specialized HCM care can change lives for patients and families.

This conversation was recorded 5/21/26

Lisa Salberg welcomes Steven Kelley and Matt Grant to discuss HCMA’s new discussion group for men 40-ish and under living with HCM. The conversation explores friendship, mental health, dating, devices, and building a supportive space where younger men can openly share their experiences and connect with others facing similar challenges.

This conversation was recorded May 15, 2026.

Lisa Salberg and Dr. Michael Ayers explore the rapidly evolving world of HCM treatment, from myosin inhibitors and clinical trials to AFib management and patient-centered care. The episode also dives into advocacy, drug safety concerns, and why personalized treatment strategies matter more than ever for people living with hypertrophic cardiomyopathy.

This conversation was recorded May 15, 2026.

Lisa Salberg and Dr. Marty Maron break down the rapidly changing landscape of HCM treatment, including the growing role of myosin inhibitors and what new clinical trial data could mean for patients. The conversation also explores beta blockers, shared care models, Centers of Excellence, and why personalized treatment matters more than ever.

This conversation was recorded May 8, 2026.

Lisa Salberg welcomes Ram Khandelwal and Pallari Kamat for a global conversation about expanding HCM awareness and patient advocacy across India. The episode explores the challenges of diagnosis, healthcare access, and education while highlighting efforts to build stronger support systems for patients and families worldwide.

This conversation was recorded May 7, 2026.

Lisa Salberg and Dr. Marty Maron break down major new clinical trial results that could change treatment for patients with non obstructive HCM. They explain what the Acacia HCM trial found, why experts call it a transformative moment, and what the next steps could mean for patients around the world.

This conversation was recorded May 5, 2026.